Response by Liang and Shimada to Letter Regarding Article "Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy"
Circ Heart Fail
.
2022 Jun;15(6):e009568.
doi: 10.1161/CIRCHEARTFAILURE.122.009568.
Epub 2022 Apr 20.
Authors
Lusha W Liang
1
,
Yuichi J Shimada
1
Affiliation
1
Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York.
PMID:
35727883
PMCID:
PMC9228502
DOI:
10.1161/CIRCHEARTFAILURE.122.009568
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Cardiomyopathy, Hypertrophic* / diagnosis
Heart Failure*
Humans
Proteomics
Substances
Biomarkers
Grants and funding
18CDA34110245/AHA/American Heart Association-American Stroke Association/United States
R01 HL157216/HL/NHLBI NIH HHS/United States